p16免疫细胞学与HPV分型在自采样HPV阳性女性中的分流评估
本研究在中国73699名自采样女性中评估p16免疫细胞学与HPV分型对HPV阳性者的分流效果。共3510名HPV阳性女性纳入分析,p16联合细胞学或基因型的多种分流策略在CIN3+ NPV≥98%前提下,较ASC-US+或指南策略呈现更优的敏感性与特异性平衡。
要点
- p16阳性率36.3%,高于ASC-US+的22.2%,敏感性更高但特异性更低。
- p16评分3+及HPV16/33/58/31+且p16+两种策略优于ASC-US+分流。
- 四种p16联合策略(含ASC-US+或p16+等)优于指南策略,更好平衡病变检出与阴道镜转诊。
核心结论
- 调整p16染色评分或作为液基细胞学辅助工具或联合基因型,可用于HPV阳性自采样分流。
研究设计与样本
- 在中国通过SeqHPV assay对73699名女性自采样进行HPV筛查的队列研究。
主要发现
- 3510名HPV阳性女性中检出422例(12.0%)CIN2+和247例(7.0%)CIN3+。
- p16阳性率为36.3%,ASC-US+阳性率为22.2%,p16敏感性更高但特异性更低(P<0.0001)。
- p16评分3+和HPV16/33/58/31+且p16+两种分流策略优于ASC-US+策略。
- ASC-US+或p16+、LSIL+或p16+、HPV16+或p16+、HSIL+或p16+或HPV16+四种策略优于指南策略。
关键数值与推荐
- 分流策略满意的标准为CIN3+的NPV≥98%且较对照(ASC-US+分流和指南策略)提升敏感性与特异性。
- 指南策略为HPV16/18+或ASC-US+。
临床怎么用
- 对自采样HPV阳性女性,可考虑采用p16免疫细胞学调整评分或联合细胞学/基因型进行分流,以优化阴道镜转诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Self-sampling for human papillomavirus (HPV) testing is an effective option to increase the cervical screening coverage. How to best triage HPV-positive self-samples remains controversial. Here, we evaluated the performance of a novel p16INK4a immunocytology approach (p16) and HPV genotyping in triaging HPV-positive self-samples. METHODS: A cohort of 73699 women were screened via SeqHPV assay on self-samples. HPV-positive women who met any sequential positive result of HPV16/18 or VIA or p16 were referred for colposcopy. A triage strategy was considered favorable if the NPV for CIN3+ was ≥98%, combined with an improvement of sensitivity and specificity in comparison to the comparator, being the 'ASC-US+' triage and the guideline strategy (HPV16/18+ or ASC-US+). RESULTS: A total of 3510 HPV-positive women were included, 422 (12.0%) CIN2+ and 247 (7.0%) CIN3+ were identified. The positivity of p16 and ASC-US+ were 36.3% and 22.2%, respectively. p16 was more sensitive and less specific than ASC-US+ (P < 0.0001). However, when combined p16 with cytology or genotypes, two triage strategies were superior to the 'ASC-US+' strategy: p16 scored 3+; HPV16/33/58/31+ &p16+. Moreover, four strategies were favorable to the guideline strategy: ASC-US+ or p16+; LSIL+ or p16+; HPV16+ or p16+; HSIL+ or p16+ or HPV16+. These strategies achieved better balance between diseases detection and colposcopy referral. CONCLUSIONS: Our findings indicate the promising utility of p16 immunocytology via adjusting the staining score or serving as an ancillary tool to liquid-based cytology or combining with genotyping for the triage of HPV-positive self-samples, which promotes the precise screening of cervical cancer.
引用
- Song F, Belinson JL, Yan P, et al. Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China. Gynecol Oncol. 2021. PMID: 34059349. doi:10.1016/j.ygyno.2021.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。